Intranasal diamorphine integrated care pathway for paediatric analgesia in the accident and emergency department [2]

Emergency Medicine Journal

Volumn 23, Issue 12, 2006, Pages 959-

  Gahir, Kalvinder K ^a,b   Ransom, P A ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; MORPHINE; NALOXONE;

ANALGESIA; CLINICAL OBSERVATION; CLINICAL PATHWAY; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HUMAN; INFORMED CONSENT; LETTER; LIMB FRACTURE; MEDICAL AUDIT; PAIN ASSESSMENT; PATIENT SAFETY; PEDIATRIC ANESTHESIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADMINISTRATION, INTRANASAL; ANALGESICS, OPIOID; CHILD; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; HEROIN; HUMANS;

EID: 33845351247     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.034637     Document Type: Letter

References (3)

1. Kendall JM, Reeves BC, Latter VS, on behalf of the Nasal Diamorphine Trial Group. Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures. BMJ 2001;332:261-5.
2. Campbell H, Hotchkiss R, Bradshaw N, et al. Integrated care pathways. BMJ 1998;316:133-7.
3. National Institute for Clinical Excellence. Principles for best practice in clinical audit. Oxford: Radcliffe Medical Press, 2002.